# ZILEUTON
> **ANDA215742** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2022-10-11
## Drug
- **FDA Application Number:** ANDA215742
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ZILEUTON
- **Generic name:** ZILEUTON
- **Active ingredients:** ZILEUTON
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANNORA PHARMA
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2022-10-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215742)
---
*MORVS · CC0 1.0*